EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Impact of sulfonamide allergy label on clinical outcomes of acute cystitis: a retrospective matched cohort study

Ray Moussa, Tyler Miluski, Gisoo Ghaffari, Taha Al-Shaikhly iD

Internal Medicine Journal · 2025

DOI: 10.1111/imj.70057 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Internal Medicine Journal, 2025. Verfasst von Ray Moussa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Section of Allergy, Asthma and Immunology, Department of Medicine, Penn State College of Medicine, Hershey, Pennsylvania, USA. Hauptthemen laut MEDLINE: Cystitis, Sulfonamides, Anti-Bacterial Agents, Drug Hypersensitivity. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cystitis is a common infection in an otherwise healthy individual. Sulfonamide antibiotics are first‐line treatment options. Sulfonamide allergy label (SAL) is the second most common antibiotic allergy label in electronic health records, yet its impact on clinical outcomes in patients with cystitis is not well‐characterised.

Aims

The aim of this study is to characterise the impact of SAL on clinical outcomes of acute cystitis.

Methods

In this retrospective matched cohort study utilising the TriNetX US Collaborative Network (Cambridge, MA, USA), adult patients with cystitis were categorised based on their SAL status. The 28‐day risks of acute pyelonephritis and Clostridium difficile infection and the risk of recurrent or relapsed cystitis (defined as cystitis 15–28 days post‐indexed cystitis) were contrasted. Antibiotic prescription practices within 14 days of the index cystitis were also compared.

Results

When comparing 19 767 patients with cystitis and SAL to an equal number of matched controls, more patients with SAL had acute pyelonephritis (RR 1.27; 95% CI 1.08–1.48; P = 0.003; corrected P = 0.027) within 28 days of index. More patients with SAL developed recurrent/relapsed cystitis 15–28 days post‐indexed cystitis (RR 1.19; 95% CI 1.08–1.31; P = 0.001; corrected P = 0.009) as compared to controls. SAL altered antibiotic prescription practices with under‐utilisation of trimethoprim and sulfamethoxazole and increased utilisation of alternative antibiotics, including fluoroquinolones and nitrofurantoin, which was associated with an increased risk of Clostridium difficile infection.

Conclusions

SAL alters antibiotic prescription practices and is associated with a slightly increased risk of poor outcomes in adult patients with cystitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CystitisSulfonamidesAnti-Bacterial AgentsDrug HypersensitivityDrug LabelingHumansRetrospective StudiesFemaleMaleMiddle AgedAgedAcute DiseaseAdultTreatment OutcomeCohort StudiesPyelonephritisClostridium Infections

Stichwörter der Autor:innen

acute cystitisantibiotic allergyde‐labellingsulfa allergysulfonamide allergy label

Substanzen

SulfonamidesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Section of Allergy, Asthma and Immunology, Department of Medicine, Penn State College of Medicine, Hershey, Pennsylvania, USA.

ORCID-Profile: Taha Al-Shaikhly

Förderung

  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences

Zitieren

APA

Moussa, R., Miluski, T., Ghaffari, G., & Al-Shaikhly, T. (2025). Impact of sulfonamide allergy label on clinical outcomes of acute cystitis: a retrospective matched cohort study. Internal Medicine Journal. https://doi.org/10.1111/imj.70057

Vancouver

Moussa R, Miluski T, Ghaffari G, Al-Shaikhly T. Impact of sulfonamide allergy label on clinical outcomes of acute cystitis: a retrospective matched cohort study. Internal Medicine Journal. 2025. doi:10.1111/imj.70057

BibTeX
@article{Moussa2025,
  author = {Moussa, Ray and Miluski, Tyler and Ghaffari, Gisoo and Al-Shaikhly, Taha},
  title = {Impact of sulfonamide allergy label on clinical outcomes of acute cystitis: a retrospective matched cohort study},
  journal = {Internal Medicine Journal},
  year = {2025},
  doi = {10.1111/imj.70057}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche